Long-term research on Sermorelin and Ipamorelin has generally demonstrated excellent tolerability, with the primary adverse events being mild injection site irritation
It has recently been reported that human GLP-1 analogues were more effective in reducing the occurrence of major adverse cardiovascular events, myocardial infarctions, and hospitalizations due to cardiovascular causes when compared to exendin-based GLP-1RAs [71]
3,4 These incretins are rapidly inactivated by DPP-4, an enzyme expressed throughout the vascular endothelial cells, venous capillary beds, gut, liver, lungs, and kidneys
Production of succinic acid through overexpression of NAD(+)-dependent malic enzyme in an Escherichia coli mutant
Plant Cell 12(January):97109
Glucagon-like peptide-1 7-36: A physiological incretin in man